• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXSL1900010 重组抗血管内皮生长因子(VEGF)单抗注射液 bevacizumab Injection Biological Products(2) New Drug Application 2019-02-19 华兰基因工程有限公司 Hualan Genetic Engineering Co Ltd In Review 2019-02-18 view
CXSL1400094 重组抗血管内皮生长因子(VEGF)单抗注射液(贝伐单抗) bevacizumab Injection Biological Products(2) New Drug Application 2014-11-17 华兰基因工程有限公司 Hualan Genetic Engineering Co Ltd Certificate Issued 2016-08-23 view
CXSS2000013 贝伐珠单抗注射液 bevacizumab Injection Biological Products(2) New Drug Application 2020-04-22 山东绿叶制药有限公司 Shandong Luye Pharmaceutical Co Ltd In Review 2020-04-21 view
CYSB2200054 贝伐珠单抗注射液 bevacizumab Injection Biological Products(原2) Supplementary Application 2022-02-21 Bio-Thera Solutions Ltd view
JYSB1600045 贝伐珠单抗注射液 bevacizumab Injection Biological Products Supplementary Application 2016-04-05 罗氏(中国)投资有限公司 Roche (China) Holding Ltd Certificate Issued 2016-10-10 view
CYSB2200262 贝伐珠单抗注射液 bevacizumab Injection Biological Products(原2) Supplementary Application 2022-11-22 view
CYSB2400103 贝伐珠单抗注射液 bevacizumab Injection Biological Products Supplementary Application 2024-05-01 Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group view
JXSL1300020 贝伐珠单抗注射液 bevacizumab Injection Biological Products Import Drug Application 2013-04-03 Roche Pharma (Schweiz) Ltd Certificate Issued 2015-01-08 view
JYSB2000530 贝伐珠单抗注射液 bevacizumab Injection Biological Products Supplementary Application 2020-10-26 罗氏(中国)投资有限公司 Roche (China) Holding Ltd Filed 2020-11-09 view
CYSB2300064 贝伐珠单抗注射液 bevacizumab Injection Biological Products Supplementary Application 2023-03-23 Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group view
CXSS2000046 贝伐珠单抗注射液 bevacizumab Injection Biological Products(3.3) New Drug Application 2020-09-05 东曜药业有限公司 TOT Biopharm Co Ltd Certificate Issued 2021-12-03 view
CYSB2200053 贝伐珠单抗注射液 bevacizumab Injection Biological Products(原2) Supplementary Application 2022-02-21 Bio-Thera Solutions Ltd view
CXSS1900004 贝伐珠单抗注射液 bevacizumab Injection Biological Products(2) New Drug Application 2019-01-31 信达生物制药(苏州)有限公司 Innovent Biologics (Suzhou) Co Ltd Certificate Issued 2020-06-22 view
CXSL2101206 贝伐珠单抗注射液 bevacizumab Injection Biological Products(2.2) New Drug Application 2021-07-20 Suzhou Suncadia Biopharmaceuticals Co Ltd view
CYSB2100040 贝伐珠单抗注射液 bevacizumab Injection Biological Products(原2) Supplementary Application 2021-01-25 齐鲁制药有限公司 QILU Pharmaceutical Co Ltd In Review 2021-01-25 view
CXSS2300048 贝伐珠单抗注射液 bevacizumab Injection Biological Products(3.3) New Drug Application 2023-07-03 Hualan Genetic Engineering Co Ltd view
CYSB2101319 贝伐珠单抗注射液 bevacizumab Injection Biological Products(3.3) Supplementary Application 2021-12-31 TOT Biopharm Co Ltd view
JYSB2400153 贝伐珠单抗注射液 bevacizumab Injection Biological Products Supplementary Application 2024-07-16 view
CXSL2200079 贝伐珠单抗注射液 bevacizumab Injection Biological Products(3.3) New Drug Application 2022-02-11 Shanghai Henlius Biotech Co Ltd view
JYSB1500238 贝伐珠单抗注射液 bevacizumab Injection Biological Products Supplementary Application 2015-09-29 罗氏(中国)投资有限公司 Roche (China) Holding Ltd Certificate Issued 2015-12-11 view